Welcome to our dedicated page for Agilon Health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on Agilon Health stock.
The agilon health, inc. (AGL) news page on Stock Titan aggregates company-specific updates for investors and observers who follow its role in value-based healthcare. agilon health describes itself as a trusted partner empowering physicians to transform health care in their communities, and its news flow reflects this focus on physician partnerships and senior care.
Company announcements commonly cover financial results, including quarterly earnings releases that discuss membership on the agilon platform, revenue from medical services, and performance within its value-based care arrangements. These releases often provide detail on metrics related to Medicare Advantage members and other value-based models for senior patients.
agilon health news also includes items on leadership and governance, such as changes in executive roles, the establishment of an Office of the Chairman, and updates on board-level decisions. In addition, the company frequently announces participation in healthcare and investor conferences, where its management team discusses the business, its Total Care Model, and its value-based care strategy.
Another recurring theme in agilon health’s news is research related to value-based care. The company has highlighted studies examining how its model may relate to clinical and quality outcomes, healthcare utilization, and access to primary care for Medicare patients. These research-focused releases describe how physicians working within agilon’s value-based care framework manage senior patients and how payment models may influence practice patterns.
Visitors to this page can review these types of updates in one place, from earnings announcements and NYSE compliance notices to conference appearances and research publications connected to agilon health’s value-based Total Care Model for senior patients.
agilon health (NYSE: AGL) has announced its participation in the 45th Annual TD Cowen Healthcare Conference. The company will deliver a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time.
Investors and interested parties can access a simultaneous webcast of the presentation through the 'Events & Presentations' section on agilon health's investor relations website. The presentation will also be available for on-demand replay shortly after its completion.
agilon health (NYSE: AGL) has announced it will release its fourth quarter and full year 2024 financial results after market close on Tuesday, February 25, 2025. The company will host a conference call at 4:30 PM Eastern Time on the same day to discuss the results.
Participants can join the conference call by dialing (833) 470-1428 (U.S.) or +1 (404) 975-4839 (international) using participant code 599648. A simultaneous webcast will be available through the 'Events & Presentations' section of agilon's Investor Relations website. An on-demand replay will be accessible shortly after the call concludes.
agilon health (NYSE: AGL) announced significant achievements in its ACO REACH model for 2023. The company's eight Accountable Care Organizations (ACOs) generated $150 million in gross savings (13% gross savings rate), including $37 million in Medicare Trust Fund savings. Operating under full risk for approximately 90,000 Traditional Medicare beneficiaries, the ACOs achieved an impressive 95% average quality score, with four ACOs reaching 100%. Five ACOs earned High Performers Pool status, securing an additional $7 million bonus. Since 2021, agilon's REACH ACOs have accumulated $281 million in gross savings, with $71 million benefiting the Medicare Trust Fund.
agilon health reported Q3 2024 results with revenue increasing 28% to $1.45 billion. Medicare Advantage membership grew 37% to 525,000, while total platform members increased 39% to 657,000. The quarter was impacted by challenges including $60 million in prior year development costs, $65 million reduction in 2024 risk adjustment, and $25 million in higher medical expenses. The company reported a gross profit loss of $64 million and a net loss of $118 million. In response, agilon plans to exit two unprofitable partnerships and certain payor contracts by end of 2024. The company updated its full-year 2024 guidance, reflecting Q3 results and revised Q4 cost trends.
agilon health (NYSE: AGL) has announced its participation in the 2024 Wolfe Research Healthcare Conference. The company will deliver a fireside chat presentation on Tuesday, November 19, at 2:20 PM Eastern Time.
Interested parties can access a live webcast of the event through the 'Events & Presentations' section of agilon's Investor Relations website. On-demand replay of the conference will be made available shortly after the completion of each call.
agilon health (NYSE: AGL), a company focused on transforming healthcare through physician empowerment, has announced the date for its third quarter 2024 financial results release. The results will be disclosed after market close on Thursday, November 7, 2024, followed by a conference call at 4:30 PM Eastern Time on the same day.
Interested parties can join the conference call by dialing (833) 470-1428 (U.S. participants) or +1 (404) 975-4839 (international participants) and using the participant code 520026. A simultaneous webcast will be available on the company's Investor Relations website. For those unable to attend live, a replay of the call will be accessible via webcast shortly after its conclusion.
agilon health (NYSE: AGL), a company focused on empowering physicians to transform community healthcare, has announced its participation in the 2024 Wells Fargo Healthcare Conference. The event will feature a fireside chat presentation by agilon health on Wednesday, September 4, at 3:00 PM Eastern Time.
Interested parties can access a live webcast of the presentation through the 'Events & Presentations' section of agilon's Investor Relations website. For those unable to attend the live event, a replay will be made available for on-demand viewing shortly after the presentation concludes.
This participation in a major healthcare conference underscores agilon health's commitment to engaging with investors and industry professionals, potentially providing insights into the company's strategies and outlook in the evolving healthcare landscape.
agilon health (NYSE: AGL) reported Q2 2024 results with revenue increasing 39% to $1.5 billion and Medicare Advantage membership growing 38% to 513,000. Total members on the agilon platform reached 645,000, up 40%. The company maintained its 2024 Medical Margin and Adjusted EBITDA guidance despite retroactive membership adjustments due to contract terminations. Key financials include:
- Gross profit: $32 million (down from $55 million in Q2 2023)
- Net loss: $31 million (increased from $17 million in Q2 2023)
- Medical margin: $106 million (down from $134 million in Q2 2023)
- Adjusted EBITDA: $3 million loss (compared to $12 million earnings in Q2 2023)
agilon is making progress on its performance action plan, focusing on refining payor relationships, increasing PCP engagement, improving data visibility, and accelerating operating efficiency.
agilon health (NYSE: AGL), a company focused on empowering physicians to transform healthcare, has announced its plans to release second quarter 2024 financial results. The results will be disclosed after the market closes on Tuesday, August 6, 2024, followed by a conference call at 4:30 PM Eastern Time to discuss the outcomes. Interested parties can access the call via phone or webcast, with details provided for both U.S. and international participants. A replay of the call will be made available on the company's Investor Relations website for on-demand listening after the event concludes.
agilon health announced the appointment of Karthik Rao, M.D., as its permanent Chief Medical Officer (CMO), effective immediately. Dr. Rao has been serving as interim CMO since February 2024 and was previously senior medical director and vice president of network performance at agilon. With nearly a decade of experience as a practicing internal medicine physician, Dr. Rao will co-lead clinical strategy and oversee clinical programs alongside Chief Clinical Officer Kevin Spencer, M.D., who brings over 25 years of experience in value-based care. Both will report to CEO Steve Sell and aim to enhance provider performance across agilon's Physician Network.